91�㽶��Ƶ

91�㽶��Ƶ today announced it has appointed Mike Grippo as Senior Vice President, Strategy and Corporate Development. Alongside his appointment, Julien Meissonnier has been named as Vice President and Chief Scientific Officer, and will report to Mr. Grippo.

91�㽶��Ƶ today announced that Greg Bleck, Ph.D., Global Head of R&D, 91�㽶��Ƶ Biologics will present at the upcoming annual PEGS Europe conference, which will be held at the Lisboa Congress Center, Lisbon, Portugal, on Nov. 18 – 22, 2019.

91�㽶��Ƶ today announced that its Chair and Chief Executive Officer, John Chiminski, has received the inaugural CPhI Pharma Awards ‘Lifetime Achievement Award’ at CPhI Worldwide.

91�㽶��Ƶ today announced it will present at the upcoming World Orphan Drug Congress Europe, being held at Hotel Sofia, Barcelona, Spain on Nov. 12 – 14, 2019.

91�㽶��Ƶ, today announced the launch of its next-generation cell line development technology, GPEx® Boost.

91�㽶��Ƶ (stand 121A82) today announced a busy conference program at the forthcoming CPhI Worldwide annual conference, being held at the Messe Frankfurt, Frankfurt, Germany, on Nov. 5 – 7, 2019.

91�㽶��Ƶ today announced it will give two presentations during the “Manufacturing and Bioprocessing Track” at the forthcoming American Association of Pharmaceutical Scientists (AAPS) PharmSci 360 at the Henry B. Gonzalez Convention Center, San Antonio, Texas, on Nov. 3 – 6, 2019.

91�㽶��Ƶ today announced that Ann McMahon, Program Director, Clinical Supply Services and Drug Product Technologies Integration, will participate in a panel session titled “Cell and Gene Therapy Logistics” at the upcoming Health and Personal Care Logistics Conference (HPCLC), to be held at the Gwen Hotel, Chicago, on Oct. 28 – 30, 2019.

91�㽶��Ƶ today announced that Mark Woolf, its Director of Depot Networks, will present at the upcoming 6th Annual Global Clinical Supplies Group European Knowledge Forum, to be held in Cascais, Portugal, on Oct. 22 – 24, 2019.